175 related articles for article (PubMed ID: 18036300)
1. [Value of thyroid transcription factor-1 in identification of the prognosis of bronchioloalveolar carcinoma].
Wang CL; Yue DS; Zhang ZF; Zhan ZL; Sun LN
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2350-4. PubMed ID: 18036300
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.
Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J
Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
Saad RS; Liu YL; Han H; Landreneau RJ; Silverman JF
Hum Pathol; 2004 Jan; 35(1):3-7. PubMed ID: 14745718
[TBL] [Abstract][Full Text] [Related]
4. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV
Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
Saad RS; Cho P; Silverman JF; Liu Y
Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
[TBL] [Abstract][Full Text] [Related]
6. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases.
Lau SK; Desrochers MJ; Luthringer DJ
Mod Pathol; 2002 May; 15(5):538-42. PubMed ID: 12011259
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
Cai YC; Banner B; Glickman J; Odze RD
Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
[TBL] [Abstract][Full Text] [Related]
8. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
9. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies.
Goldstein NS; Thomas M
Am J Clin Pathol; 2001 Sep; 116(3):319-25. PubMed ID: 11554157
[TBL] [Abstract][Full Text] [Related]
10. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
[TBL] [Abstract][Full Text] [Related]
11. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
Su YC; Hsu YC; Chai CY
Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
[TBL] [Abstract][Full Text] [Related]
12. Bronchioloalveolar differentiation in lung adenocarcinomas.
Dukić N; Babić B; Eri Z; Zec D; Lovrenski A; Kolarov V
Bosn J Basic Med Sci; 2011 Nov; 11(4):248-52. PubMed ID: 22117833
[TBL] [Abstract][Full Text] [Related]
13. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
Al-Zahrani IH
Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
[TBL] [Abstract][Full Text] [Related]
14. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
15. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
Tsao SC; Su YC; Wang SL; Chai CY
Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 7 and thyroid transcription factor - 1 levels in patients with lung cancer complicated with superior vena cava syndrome and their correlation with clinicopathological characteristics.
Tong L; Xu H
J BUON; 2019; 24(6):2294-2302. PubMed ID: 31983097
[TBL] [Abstract][Full Text] [Related]
17. Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer.
Luo HT; Liang CX; Luo RC; Gu WG
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28827446
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry of Cytokeratin 7, Cytokeratin 20 and Thyroid Transcription Factor-1 in Metastatic Carcinoma of Cervical Lymph Node Biopsy for Identification of Pulmonary Origin in Rajavithi Hospital.
Kuakpaetoon T
J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S172-6. PubMed ID: 29927559
[TBL] [Abstract][Full Text] [Related]
19. A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: clinicopathologic analysis, molecular features, and possible pitfalls in routine practice.
Casali C; Rossi G; Marchioni A; Sartori G; Maselli F; Longo L; Tallarico E; Morandi U
J Thorac Oncol; 2010 Jun; 5(6):830-6. PubMed ID: 20521350
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of bronchioloalveolar carcinoma component in lung adenocarcinoma.
Lin DM; Ma Y; Zheng S; Liu XY; Zou SM; Wei WQ
Histol Histopathol; 2006 Jun; 21(6):627-32. PubMed ID: 16528673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]